New molecular determinant for inactivation of the human L-type α1C Ca2+ channel

被引:15
|
作者
Soldatov, NM [1 ]
Zhenochin, S
AlBanna, B
Abernethy, DR
Morad, M
机构
[1] NIA, NIH, Gerontol Res Ctr, Baltimore, MD 21224 USA
[2] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA
来源
JOURNAL OF MEMBRANE BIOLOGY | 2000年 / 177卷 / 02期
关键词
calcium channel; inactivation; mutant; Ca2+ overloading;
D O I
10.1007/s002320001106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Molecular cloning of the human fibroblast Ca2+ channel pore-forming alpha(1C) subunit revealed (Soldatov, 1992. Proc. Natl. Acad. Sci. USA 89:4628-4632) a naturally occurring mutation g(2254) --> a that causes the replacement of the conservative alanine for threonine at the position 752 at the cytoplasmic end of transmembrane segment IIS6. Using stably transfected HEK293 cell lines, we have compared electrophysiological properties of the conventional alpha(1C,77) human recombinant L-type Ca2+ channel with those of its mutated isoform alpha(1C,94) containing the A752T replacement. Comparative quantification of steady-state availability of the current carried by alpha(1C,94) and alpha(1C,77) showed that A752T mutation prevented a large (approximate to 25%) fraction of the current carried by Ca2+ or Ba2+ from fully inactivating. This mutation, however, did not appear to alter significantly the Ca2+-dependence and kinetics of decay of the inactivating fraction of the current or its voltage-dependence. The data suggests that Ala752 at the cytoplasmic end of IIS6 might serve as a molecular determinant of the Ca2+ channel inactivation, possibly regulating the voltage-dependence of its availability.
引用
收藏
页码:129 / 135
页数:7
相关论文
共 50 条
  • [1] New Molecular Determinant for Inactivation of the Human L-Type α1C Ca2+ Channel
    N.M. Soldatov
    S. Zhenochin
    B. AlBanna
    D.R. Abernethy
    M. Morad
    The Journal of Membrane Biology, 2000, 177 : 129 - 135
  • [2] Clotrimazole inhibits the recombinant human cardiac L-type Ca2+ channel α1C subunit
    Fearon, IM
    Ball, SG
    Peers, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (03) : 547 - 554
  • [3] Farnesol blocks the L-type Ca2+ channel by targeting the α1C subunit
    Luft, UC
    Bychkov, R
    Gollasch, M
    Gross, V
    Roullet, JB
    McCarron, DA
    Ried, C
    Hofmann, F
    Yagil, Y
    Yagil, C
    Haller, H
    Luft, FC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (04) : 959 - 966
  • [4] Role of carboxyl terminal region of L-type Ca2+ channel α1C subunit (Cav1.2) in the Ca2+ channel inactivation.
    Komuro, Y
    Nagao, T
    Ichijo, H
    Adachi-Akahane, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 243P - 243P
  • [5] Novel determinant of action of dihydropyridine agonists in voltage-dependent L-type Ca2+ channel α1c subunit
    Nagao, T
    Yamaguchi, S
    Okamura, Y
    Adachi-Akahane, S
    CIRCULATION, 2000, 102 (18) : 200 - 200
  • [6] Hypoxia inhibits the recombinant alpha(1C) subunit of the human cardiac L-type Ca2+ channel
    Fearon, IM
    Palmer, ACV
    Balmforth, AJ
    Ball, SG
    Mikala, G
    Schwartz, A
    Peers, C
    JOURNAL OF PHYSIOLOGY-LONDON, 1997, 500 (03): : 551 - 556
  • [7] L-type Ca2+ channel α1c subunit isoform switching in failing human ventricular myocardium
    Yang, YB
    Chen, XW
    Margulies, K
    Jeevanandam, V
    Pollack, P
    Bailey, BA
    Houser, SR
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (06) : 973 - 984
  • [8] Novel determinant of action of DHP agonist in voltage-dependent L-type Ca2+ channel α1C subunit
    Yamaguchi, S
    Okamura, Y
    Nagao, T
    Adachi-Akahane, S
    CALCIUM SIGNALI NG, 2001, 331 : 124 - 126
  • [9] Molecular determinant for run-down of L-type Ca2+ channels localized in the carboxyl terminus of the α1C subunit
    Kepplinger, KJF
    Förstner, G
    Kahr, H
    Leitner, K
    Pammer, P
    Groschner, K
    Soldatov, NM
    Romanin, C
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 529 (01): : 119 - 130
  • [10] Modeling of the inactivation process of L-type Ca2+ channel
    Suzuki, S
    Findlay, I
    Kurachi, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 223P - 223P